Clinical Trial

Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated September 16, 2022 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
To evaluate if adjuvant concurrent chemoradiotherapy is associated with a recurrence-free survival benefit in comparison with radiotherapy alone in selected intermediate risk cervical cancer after radical surgery.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-03-10.
Status change: Not Yet Recruiting → Recruiting 2022-09-14
Trial Details
NCT Number NCT05277688
Lead Sponsor Ruijin Hospital
Conditions Cervical Cancer
Enrollment 340 participants
Start Date 2022-03-15
Primary Completion 2025-12-30 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2022-09-16